When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LLY - Did Eli Lilly Just Get a Leg Up on Novo Nordisk?
Eli Lilly and Company
2024-07-13 05:30:00 ET
Pharmaceutical giant Eli Lilly (NYSE: LLY) has gotten off to an incredible start in 2024.
The company's diabetes and obesity care treatments, Mounjaro and Zepbound, continue to support unprecedented growth for Lilly in a heated race with its rival Novo Nordisk , the maker of glucagon-like peptide 1 (GLP-1) agonists Ozempic, Wegovy, Rybelsus, and Saxenda.
Although GLP-1 medications are in the spotlight for Lilly, investors should be keen to learn that the company just achieved another milestone.